REFRACTORY CHRONIC COUGH
Clinical trials for REFRACTORY CHRONIC COUGH explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHRONIC COUGH trials appear
Sign up with your email to follow new studies for REFRACTORY CHRONIC COUGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drugs, new hope for nagging coughs that Won't quit
Symptom relief Recruiting nowThis study is testing if two existing medications, duloxetine and amitriptyline, can reduce how often people with a hard-to-treat chronic cough need to cough. It will involve 50 participants who have had a persistent cough for over a year. The study will carefully compare differe…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New hope for people with constant, unexplained cough
Symptom relief Recruiting nowThis study is testing an investigational drug called BLU-5937 to see if it can safely reduce coughing in adults with a persistent, hard-to-treat cough that has lasted over a year. About 975 participants will be randomly assigned to receive either the study drug or a placebo for 2…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE3 • Sponsor: Bellus Health Inc. - a GSK company • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
Can your phone teach you to cough less? new app trial investigates
Symptom relief Recruiting nowThis study is testing whether a smartphone app can help adults with a long-lasting, hard-to-treat cough. Participants wear a special watch that tracks their coughs and follow lessons in the app that teach techniques to reduce coughing. The main goal is to see if using the app for…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: NA • Sponsor: Hyfe Inc • Aim: Symptom relief
Last updated Mar 17, 2026 13:08 UTC